1. Home
  2. DRTS vs CRI Comparison

DRTS vs CRI Comparison

Compare DRTS & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.44

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$33.21

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
CRI
Founded
2015
1865
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
DRTS
CRI
Price
$14.44
$33.21
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$17.80
★ $42.29
AVG Volume (30 Days)
441.6K
★ 1.4M
Earning Date
11-19-2026
10-26-2026
Dividend Yield
N/A
★ 3.09%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 3.26
Revenue
N/A
★ $2,898,426,000.00
Revenue This Year
N/A
$2.74
Revenue Next Year
$1,235.59
$1.73
P/E Ratio
★ N/A
$9.91
Revenue Growth
N/A
★ 1.91
52 Week Low
$3.43
$27.15
52 Week High
$15.79
$44.44

Technical Indicators

Market Signals
Indicator
DRTS
CRI
Relative Strength Index (RSI) 47.85 57.03
Support Level $13.73 $31.93
Resistance Level $15.01 $33.73
Average True Range (ATR) 0.58 1.02
MACD -0.10 0.55
Stochastic Oscillator 9.46 98.82

Price Performance

Historical Comparison
DRTS
CRI

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: